LODE Comstock Inc.
Industrial Organic Chemicals · NYSE · SEC CIK 1120970 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-52.2%
TTM net income YoY7.1%
TTM EPS YoY—
Revenue 3-yr CAGR15.7%
Net income 3-yr CAGR—
Margins
Gross margin-151.8%
Operating margin-3,535.2%
Net margin-3,680.5%
FCF margin—
EBITDA margin-3,173.9%
Returns
ROE-38.2%
ROA-27.2%
ROIC (approx.)-40.2%
Asset turnover0.01x
Leverage & solvency
Liabilities / assets22.9%
Debt / equity0.00x
Current ratio3.31x
Interest coverage-67.29x
Cash quality & payout
Operating cash flow / net income0.64x
Accruals ratio-9.8%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $367,251 | $272,824 | $313,456 | $374,356 | $54,079 | $339,546 | $785,815 | $1.60M |
| Cost of revenue | $973,312 | $1.17M | $599,810 | $601,768 | $324,397 | $814,001 | $886,796 | $451,938 |
| Gross profit | -$606,061 | -$896,073 | -$286,354 | -$227,412 | -$270,318 | -$474,455 | -$100,981 | $1.15M |
| R&D expense | $2.42M | $2.28M | $2.10M | $4.67M | $2.23M | $2.12M | $3.30M | $14.22M |
| SG&A expense | $8.12M | $7.35M | $6.57M | $6.67M | $6.11M | $4.64M | $3.26M | $3.21M |
| Operating income | $2.16M | -$26.94M | -$8.94M | -$13.23M | -$10.22M | -$7.67M | -$7.04M | -$15.84M |
| Interest expense | $168,719 | $222,406 | $147,993 | $158,518 | $336,076 | $774,062 | $659,144 | $673,253 |
| Net income | -$753,455 | -$25.47M | -$9.38M | -$13.27M | -$12.89M | -$7.83M | -$9.09M | -$22.82M |
| EBITDA | $2.88M | -$25.91M | -$7.55M | -$11.56M | -$9.05M | -$7.03M | -$6.66M | -$15.47M |
| EPS (basic) | -0.01 | -0.34 | -0.14 | — | -0.31 | -0.27 | -0.37 | — |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $39.45M | $31.41M | $52.97M | $16.95M | $31.71M | $18.59M | $16.95M | $954,271 |
| Short-term investments | — | — | — | — | — | — | — | $0 |
| Receivables | $666,313 | $1.34M | $311,600 | $1.29M | $1.80M | $3.22M | $1.29M | $2.42M |
| Current assets | $47.74M | $58.13M | $76.97M | $20.66M | $35.13M | $22.99M | $20.66M | $12.56M |
| PP&E, net | $30.10M | $35.60M | $36.10M | $29.89M | $27.34M | $27.26M | $29.89M | $8.61M |
| Goodwill | $1.51M | $1.51M | $1.51M | $1.51M | — | — | $1.51M | $0 |
| Intangibles | $10.80M | $9.65M | $23.96M | $26.45M | $25.42M | $26.16M | $24.94M | $5.86M |
| Total assets | $182.49M | $193.55M | $218.13M | $169.60M | $176.29M | $148.22M | $169.60M | $91.31M |
| Current liabilities | $14.42M | $18.19M | $17.07M | $10.02M | $13.81M | $15.36M | $8.62M | $8.11M |
| Short-term debt | — | — | — | $0 | $0 | $1.78M | $0 | $97,593 |
| Long-term debt | — | — | — | $0 | $0 | $8.39M | $13.90M | $8.39M |
| Total debt | — | — | — | $0 | $0 | $10.17M | $13.90M | $8.49M |
| Total liabilities | $41.73M | $52.88M | $58.38M | $58.70M | $54.60M | $56.36M | $51.78M | $31.54M |
| Shareholders' equity | $137.43M | $137.35M | $156.43M | $107.58M | $118.39M | $88.56M | $59.55M | $59.77M |
| Net debt | — | — | — | -$16.95M | -$31.71M | -$8.41M | -$3.05M | $7.53M |
| Shares outstanding | 75.99M | 75.95M | 74.10M | 51.85M | 51.26M | 32.42M | 26.90M | 23.51M |
| Cash flow statement | ||||||||
| Operating cash flow | -$9.40M | -$10.10M | -$5.82M | -$5.90M | -$8.71M | -$4.82M | -$4.96M | -$4.32M |
| Capital expenditure | $1.10M | — | — | — | $920,617 | — | — | — |
| Free cash flow | -$10.50M | — | — | — | -$9.63M | — | — | — |
| Investing cash flow | $17.45M | -$11.46M | -$14.53M | -$10.88M | -$7.28M | -$2.00M | -$1.82M | $383,939 |
| Financing cash flow | -$2,267 | -$2,267 | $56.37M | $2.02M | $29.11M | $21.50M | $9.73M | $3.53M |
| Depreciation & amortization | $717,604 | $1.02M | $1.39M | $1.67M | $1.16M | $636,692 | $375,384 | $367,403 |
| Stock-based compensation | — | — | $321,659 | $0 | $0 | $0 | $0 | -$100,683 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.